The suppressor of cytokine signaling (SOCS) family has eight members and suppresses various cytokine signaling pathways, including IFN signaling. Therefore, some viruses have evolved molecular mechanisms for inducing SOCS proteins and thus escaping host immunity. Herpes simplex virus type 1 (HSV-1) has a mechanism for escaping from type I IFN by induction of both SOCS1 and SOCS3. In this study, expression of the eight members of the SOCS family stimulated by HSV-1 infection was comparatively analyzed by qRT-PCR. It was found that SOCS1 and SOCS3 are induced by HSV-1-infection at 4 hr post infection. However, such induction was not observed in UL13 deficient virus-infected cells, suggesting that UL13 protein kinase participates in induction of both genes. The transcription factor Sp1-binding sites of SOCS3 promoter/enhancer region were identified as the regulatory elements for induction of SOCS3 in HSV-1 infected cells. Accumulation of activated Sp1 was detectable in the nuclei of HSV-1-infected cells before induction of SOCS3. Taken together, these results suggest that HSV-1 has a potent mechanism for escaping from the IFN system. Key words herpes simplex virus type 1, suppressor of cytokine signaling, UL13.
Interferons play a crucial role in host defense against viral infections. On secretion from infected cells, IFNs induce an antiviral state in both the infected cells and in neighboring non-infected cells. IFNs confer cellular resistance against viral infection by inducing expression of ISGs such as PKR, 2 0 -5 0 oligoadenylate synthetase, Mx and ISG56 (1) . Further, IFNs play a role in the antiviral response through NK cell activation and macrophage differentiation (2) (3) (4) . Because of their antiviral properties, IFNs are used to treat various viral infectious diseases such as hepatitis B and hepatitis C virus infections (5, 6) . However, the antiviral effect of IFN is weaker than expected because many pathogenic viruses possess strategies for circumventing the host immune system, including IFNs (7) (8) (9) .
Herpes simplex virus type 1 is a member of Herpesviridae, a group of double-stranded DNA viruses with large genomes that are 125-230 kbp in length (10) . HSV-1 encodes at least 70 genes in its 150 kbp genome. Some gene products are involved in escape from innate and adaptive immunity, including NK cells, cytotoxic T-cells, complements, antibodies and the IFN system (10) . The IFN system is inhibited by these viral proteins by various means (11) . For example, HSV US11 inhibits phosphorylation of PKR and 2 0 -5 0 oligoadenylate synthetase, resulting in suppression of enzyme activation and inhibition of the antiviral effect of IFNs (12, 13) . Further, g 1 34.5 catalyzes dephosphorylation of the a subunit of protein synthesis initiation factor 2, which is phosphorylated by PKR (14) . ICP0 impairs IRF3 function and blocks transcription of ISGs (15, 16) . Moreover, we have reported that HSV induces a host inhibitory factor, SOCS 3, for IFN-stimulated JAK/STAT signaling in FL cells, a human amnion cell line (17, 18) . IFN signaling is negatively regulated by SOCS family members (19) . Activation of SOCS3 occurs in the early stage of virus infection; it therefore appears to be a very efficient system for escape from the IFN system.
The suppressor of cytokine signaling family has eight members, SOCS1 to SOCS7 and CIS (20) , all of which contain an SH2 domain and SOCS-box located near the C-terminal (21). SOCS1 and SOCS3, which have a kinase inhibitory domain, are able to inhibit JAK signaling through interaction with the phosphorylated tyrosine of JAK or gp130 via the SH2 domain, respectively (22) . In addition to the IFNs, pathogen-associated molecular patterns are potent inducers of SOCS1 and SOCS3 (20, 23) . Because SOCS proteins act as negative regulators of cytokine signaling, numerous viruses have developed mechanisms for inducing SOCS expression to aid their survival (24) . Interestingly, SOCS1-deficient mice develop severe inflammatory disease but are resistant to viral infections (25) .
Our previous findings suggest that SOCS3 is induced by factors in the virus particle or immediate early genes (IE) (17, 18) . In this study, we determined the expression level of all eight SOCS members in HSV-1 infected FL cells and found that, in addition to SOCS3, SOCS1 is induced by HSV-1 infection, as previously reported (26, 27) and that UL13 protein kinase is involved in induction of these SOCS genes. Moreover, we identified Sp1 as a factor responsible for induction of SOCS3.
MATERIALS AND METHODS

Cells and viruses
Vero cells (an African green monkey kidney cell line) were kindly supplied by RIKEN BRC cell bank (Tsukuba, Japan). FL (a human amnion cell line) and the Vero cells were cultivated with RPMI-1640 and Dulbecco's modified Eagle medium, respectively, supplemented with 10% heat-inactivated FBS at 37°C under 5% CO 2 .
The HSV-1 strain VR3 was obtained from the AATCC (Manassas, VA, USA). A UL13-defective virus derived from VR3, the VR D13 strain and a rescued strain of VRD13, VRD13R, were grown in the Vero cells (28) . These viruses were purified by ultra-centrifugation on a 10-50% sucrose gradient according to the method of Zucker (29) to remove cellular factors which could influence gene expression by the host cells, and stored in small portions at À80°C until use. Virus titers were determined by a plaque-forming assay using Vero cells.
qRT-PCR
Expression profiles of SOCS genes in mock-and HSV-1-infected cells were analyzed using qRT-PCR as follows. FL cells in 24-well culture plates were infected with HSV-1 strains purified by sucrose gradient at a MOI of 10 plaque forming units per cell and cultivated in RPMI1640 containing 10% FCS. After incubation at 37°C for the desired period, total cellular RNA was prepared using an RNAqueous-4PCR kit (Ambion, Austin, TX, USA) in accordance with the manufacturer's instructions. RNA samples were treated with DNase I (Ambion) to remove traces of genomic DNA contamination and cDNA synthesized with a PrimeScript RT reagent kit (TaKaRa Bio, Otsu, Japan) using Oligo-dT primer. qRT-PCR for SOCS genes in the cDNA was performed with pre-made probe and primer mixes (ABI, Foster City, CA, USA; Hs00705164_s1 for SOCS1, Hs00374416_m1for SOCS2, Hs00269575_s1 for SOCS3, Hs00328404_s1 for SOCS4, Hs00367107_m1 for SOCS5, Hs00377781_m1 for SOCS6, Hs00322554_m1 for SOCS7, and Hs00367082_g1 for CIS) and TaqMan Universal PCR Master Mix (ABI) on an ABI Prism 7000 system (ABI). To construct standard curves, PCR products obtained using each primer mixture were cloned into a pGEM-T Easy vector (Promega, Madison, WI, USA) and used as the standards. The results of qRT-PCR for SOCS genes were corrected against those of b-actin. The amount of b-actin was determined by qRT-PCR using SYBR Green PCR Master Mix (ABI) and primers (forward; 5 0 -TGGCACCCAGCACAATCAA-CATCA-3 0 , reverse; 5 0 -TCATACTCCTGCTTGCTCAT CCAC-3 0 ) by the 2-DDCT method.
Luciferase assay
To determine the region related to gene induction, human SOCS1 and SOCS3 enhancer/promoter regions were obtained by PCR from the cellular genomic DNA of FL cells using specific primers ( Table 1 ). The resulting PCR product was ligated into a pGEM-T Easy Vector and then recloned into the KpnI/NheI site of the Picagene reporter plasmid containing fire-fly luciferase (Toyo, Tokyo, Japan). After purification of the constructed plasmids by HiSpeed Plasmid Midi Kit (Qiagen, 
Sp1 transcription factor assay
Amounts of activated Sp1 proteins were measured with a TransAM Sp1 kit in accordance with the manufacture's instruction (Active Motif, Carlsbad, CA, USA). Mockinfected or cells infected with HSV-1 at an MOI of 10 in 10 cm dishes were washed once with ice-cold PBS containing a PIC (Roche, Penzberg, Germany) and then harvested in 10 mL of PBS/PIC with a cell scraper. The cell pellets were collected by centrifugation, resuspended in 1 mL of cold HB buffer (20 mM Hepes [pH 7.8], PIC) and swelled on ice for 15 min. The cell nuclei were collected by adding 50 mL nonidet P-40 and centrifuging at 14,000 g for 30 s, and then resuspending in 50 mL of complete lysis buffer, consisting of 10 mM DTT, 1% PIC and lysis buffer AM1 (Active Motif). After rotating for 30 min at 4°C and centrifugation at 14,000 g for 10 min, supernatants were obtained as a suspension of nuclear proteins. The amounts of nuclear proteins were measured using a Bradford assay kit (Bio-Rad, Hercules, CA, USA). The amounts of Sp1 subunit in 10 mg of nuclear protein suspension were determined with a TransAM Sp1 kit. The OD of each well at 450 nm was determined with SpectraMax 190 (Molecular Devices, Silicon Valley, CA, USA).
Western blotting
Proteins from mock infected or infected cell lysates were separated by SDS-polyacrylamide gel electrophoresis and transferred onto a polyvinylidine difluoride membrane (Immobilon-P; Millipore, Schwalbach, Germany). These membranes were analyzed by western blotting with specific antibodies as follows: anti-b-actin (Sigma, St Louis, MO, USA) anti-SOCS1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-SOCS3 (IBL, Gunma, Japan). HRP-conjugated anti-rabbit antibody or anti-mouse antibody (GE Healthcare, Buckinghamshire, UK) were used as secondary antibodies. The membranes were stained with an ECL prime Western blotting Detection Kit (GE Healthcare) and imaged with an Image Reader LAS-3000 (Fuji Film, Tokyo, Japan).
Interferon ELISA bÀinterferon protein wase measured with an ELISA kit (PBL Biomedical Laboratory, Piscataway, NJ, USA). The sensitivity of this assay is 250 pg/mL.
RESULTS
Identification of the SOCS genes induced by HSV-1-infection
To elucidate induction of SOCS genes by HSV-1 infection, the transcripts of all SOCS members were quantified comparatively by high-sensitivity qRT-PCR at 1, 2, 4 and 6 hr post-infection. Type-I IFN treatment was used as positive control and cells were harvested at 0.5, 1, 2 and 4 hr post-treatment. As shown in Figure 1 , expression of SOCS1 and SOCS3 genes was induced by HSV-1 VR3-infection (Fig. 1a) . Induction of both SOCS1 and SOCS3 reached was maximal at 4 hpi, the maxima being 8.6-fold and 14.5-fold higher than those for mock-infected cells, respectively. In contrast, induction of CIS, SOCS1, SOCS2 and SOCS3 genes was observed by type-I IFN treatment similar to previous reports (Fig. 1b) (30) . Expression of SOCS1-and 
SOCS1 and SOCS3 gene expression is induced by UL13
As shown in Figure 1 , induction of SOCS1 and SOCS3 was observed in the early stage of HSV-1 replication. In addition, UV-irradiated virus was unable to induce SOCS1 or SOCS3 (Fig. S1 ). Previous reports have suggested that herpes viral protein kinases suppress interferon signaling (28, 31, 32) . Therefore, we hypothesized that HSV-1 UL13 is involved in induction of both SOCS1 and SOCS3. To confirm this hypothesis, we compared the strength of expression of SOCS genes in HSV-1 VR3-infected cells with that in VRD13-infected cells at 4 hpi, at which time peak SOCS1 and SOCS3 expression occurs. As shown in Figure 2 , amounts of SOCS1 and SOCS3 mRNAs were markedly increased in the presence of UL13. These results indicate that UL13 protein kinase is involved in induction of the SOCS1 and SOCS3 genes. 
Determination of the transcriptional regulatory domains of SOCS1 and SOCS3
The transcriptional regulatory domains of SOCS1 and SOCS3 for HSV-1-infection and IFN-treatment were determined by luciferase assay to enable better understanding of the mechanisms for induction of these genes. FL cells that had been transfected with the luciferase gene under regulation of the SOCS1 or SOCS3 enhancer/ promoter regions were infected with the HSV-1 VR3 strain or treated with 2000 IU/mL of IFN-a2b. In accordance with the observed peaks of SOCS1-and SOCS3-induction by HSV-1-infection or IFN-treatment as shown in Figure 1 , induction of the SOCS3 gene by IFN-treatment was measured at 1 hr post-treatment, whereas the others were evaluated at 4 hr post-treatment in a luciferase assay. The promoter/enhancer regions of SOCS1 were identified between bases À96/À56 or À196/À96 for HSV-1 infection or IFN treatment, respectively (Fig. 3a,b) . The promoter/enhancer regions of SOCS3 were identified between bases À68/À18 for HSV-1 infection (Fig. 3b, i) . For induction of SOCS3 by IFN treatment, two regions were identified between À68/À18 and between À98/À68 (Fig. 3b ii) . These results indicate that activation of the SOCS1 and SOCS3 gene by HSV-1 infection did not occur via IFN pathways, but by other pathways.
Definition of the SOCS3 transcriptional factor
To investigate induction of SOCS1 and SOCS3 at the protein level, HSV-1 infected cells were analyzed by western blotting. Although induction of SOCS1 protein was minimal (data not shown), SOCS3 protein was increased in the presence of UL13 in HSV-1 infected cells (Fig. 4a) . Therefore the focus was on the SOCS3 promoter/enhancer region to determine transcriptional factors involved in up-regulation of SOCS3 gene.
A homology search of the region responsive to HSV-1-infection suggested that Sp1-and STATx-binding sites were present in the SOCS3 promoter/enhancer region (Fig. 4b) . To analyze the participation of each site, various constructs were subjected to luciferase assay (Fig. 4c) . After transfection with a Sp1-and/or STATxsubstituted SOCS3 promoter/enhancer-luciferase plasmid, FL cells were infected with HSV-1 or treated with IFN and analyzed by luciferase assay. Luciferase activity was decreased by mutation and deletion of the STATx site in the IFN-treated cell lysate but not in the HSV-1-infected cell lysate (Fig. 4d,e) . Luciferase induction was abolished by deletion of the Sp1 site in both HSV-1-infected and IFN-treated cell lysates. The STATx domain was not responsible for induction of SOCS3 in HSV-1-infected cells (Fig. 4d) . These findings indicate that STATx is not activated in HSV-1-infected cells because type I IFN was not detectable in the HSV-1-infected FL cells (data not shown). These results strongly suggest that Sp1 is the only factor involved in induction of SOCS3 in HSV-1 infection.
Detection and quantification of transcription factor Sp1 activation
To confirm the results of the luciferase assay, the DNAbinding activity of Sp1 in HSV-1-infected cells was investigated. Activated Sp1 proteins were captured to a double strand DNA sequence containing Sp1 consensus binding site and detected by ELISA format assay as described in Methods. Sp1 DNA-binding activity was markedly increased in the nuclear extract from VR3-infected cells at 4 hpi, whereas in VR D13-infected cells it was much lower (Fig. 5) .
DISCUSSION
As reported previously, in FL cells HSV-1 possesses a mechanism for escaping from IFN-induced immunity involving the IFN signal inhibitor, SOCS3 (17, 18) . In the present study, which was based on qRT-PCR, we confirmed that SOCS1 and SOCS3 are induced by HSV-1 infection in the eight members of the SOCS family. Although induction of SOCS1 was not detected in a previous study (18) , we did detect it in this study through modifications to the detection method. We found that the viral protein kinase UL13 is involved in expression of SOCS1 and SOCS3. Induction of SOCS1 and SOCS3 gene expression by HSV-1 infection occurred in a different manner to that when induced by IFN, suggesting that induction of SOCS1 and SOCS3 by HSV-1 infection is independent of the IFNs induced by viral infection. In addition, we identified Sp1 as the transcriptional regulatory factor for HSV-1 infectioninduced expression of SOCS3.
Our results indicate that both SOCS1 and SOCS3 are the target of HSV-1 when escaping from the IFN system. SOCS1 and SOCS3 are frequent targets of viral exploitation. Human respiratory syncytial virus inhibits innate antiviral responses using SOCS1, SOCS3 or CIS (33) . Among the Herpesviridae, varicella-zoster virus infection induces SOCS3 expression (34) . In the case of HSV-1, induction of SOCS1 reportedly occurs in keratinocytes (26) . Expression of SOCS1 is increased in unpolarized but not in polarized macrophages by HSV-1 infection (27) . Given that in this study induction of SOCS1 was detectable at the mRNA, but not at the protein, level in HSV-1 infected FL cells, SOCS1 induction may be dependent on the cell line.
Although HSV-1 infection is known to induce expression of SOCSs, the precise mechanism for this induction remains unknown. We initially examined infection with UV-irradiated virus. UV-irradiated virus was unable to induce SOCS1 or SOCS3 gene expression (Fig. S1 ), indicating that de novo protein synthesis in HSV-1-infected cells is necessary to induce SOCS gene expression.
Next, we focused on UL13 protein kinase. The UL13 protein kinase of HSV-1 is a member of the conserved family of herpesvirus serine-threonine protein kinases (35). Vandevenne et al. have suggested that the varicella-zoster virus-encoded protein kinase, ORF47, inhibits activation of IRF3, a key regulator of IFN-b expression (31) . BGLF4, a protein kinase encoded by EpsteinBarr virus, has also been reported to inhibit the IFN-signaling pathway (32) . ORF36 in murine g-herpesvirus 68 inhibits the interaction of IRF3 and CBP and may inhibit recruitment of CBP to the IFN-b promoter by IRF-3. Moreover, ORF36 deregulates the phosphorylated form of IRF3 and inhibits IFN production (36) . These findings suggest that conserved herpes viral protein kinases play a role in suppression of the host innate immune response. In the present study, we made the additional observation that UL13 protein kinase participates in suppression of host immunity through induction of SOCS genes.
Given that UL13 is incorporated into the virion as a tegument protein, it is possible that virion-derived UL13 protein plays a role in SOCS induction. Because IFN production is one of the initial reactions against viral infection, HSV-1 packages some suppressor proteins in its tegument for release immediately after fusion to hijack host cells (37, 38 (42, 52) . UL13 also phosphorylates and modifies cellular proteins, including elongation factor 1d (53), large subunit of RNA polymerase (54), casein kinase II beta (55) and p60 (56) . Although the precise phosphorylation profile in HSV-1 infected cells was not clear, our results suggest that Sp1 is involved in the phosphorylation cascade of UL13. Because the SOCS1 and SOCS3 mRNAs were induced at the same time in HSV-1 infected cells (Fig 1a) , it is possible that both genes shear a mechanism to induce this expression. Given that the region between À96 and À56 of SOCS1 promoter contains the Sp1 site as the only predicted transcriptional factor, Sp1 may regulate SOCS1 in HSV-1 infected cells. While all SOCS family genes have some Sp1 sites in their promoter/enhancer region, we specifically identified Sp1 as a candidate for SOCS3 induction in HSV-1-infected cells. The activity of Sp1 depends on the site of phosphorylation and target genes (57) . Although Sp1 has 23 putative phosphorylation sites and the phosphorylation site by UL13 is unclear, phosphorylation of Sp1 by UL13 may specifically induce transcription of SOCS1 and SOCS3. Further, epigenetic changes could affect the binding activity of Sp1. The DNA binding activity of Sp1 is affected by CpG methylation in the region neighboring the Sp1 binding site (58) . Although the precise methylation status of all SOCS genes has not been elucidated and differs by cell line, the Sp1 site of HSV-1 unresponsive SOCS gene promoters may be methylated. Replication of the UL13-deficient virus is significantly impaired by and highly responsive to IFN in vitro. This mutant virus was attenuated in vivo (28) . Taken together, to understand the growth and virulence of HSV-1, it is important to elucidate the precise mechanism of Sp1 activation by UL13 protein kinase.
